Ischemic Stroke Surgery Market
完整報告名稱與涵蓋範圍
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
報告摘要
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
Market Analysis
The global ischemic stroke surgery market recorded USD 2,291.16 million and is expected to grow to USD 7,266.15 million with a CAGR of 8.70% during the forecast period. Ischemic stroke surgery involves clearing blocked arteries to restore normal blood flow to the brain. This procedure plays a vital role in minimizing brain damage and supporting patient recovery.
The global ischemic stroke surgery market is growing due to a rise in physical inactivity and sedentary habits, which increase stroke risks. The introduction of advanced surgical tools and technology is improving treatment outcomes. There's also a growing preference for minimally invasive procedures.
However, the global ischemic stroke surgery industry faces challenges from limited healthcare facilities and a lack of trained professionals. On the other hand, ongoing research and rising investments are opening new growth opportunities in the global ischemic stroke surgery market.
Market Segmentation Insights
The global ischemic stroke surgery market is segmented based on the type of surgery, including Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.
In terms of product type, the global market is divided into Catheters, aspiration systems, guidewires, microcatheters, and others.
Depending on the end-users, the global ischemic stroke surgery market is classified into hospitals and clinics, ambulatory surgical centers, and others.
Regional Perspectives
The North American region is witnessing strong growth in the global ischemic stroke surgery market due to the rising number of stroke cases and increasing demand for advanced treatments like endovascular thrombectomy. With growing awareness, technological advancements, and a large aging population, the region continues to lead in stroke care innovations.
Europe is advancing the global ischemic stroke surgery market through groundbreaking research and innovative treatment methods like thrombectomy. With rising stroke cases and strong support for medical research, the region is strengthening its role in improving stroke care outcomes.
The Asia-Pacific region is driving growth in the global ischemic stroke surgery market with rising stroke cases and increasing government focus on healthcare. Ongoing clinical research and growth in access to advanced care is reported to be that which is improving stroke results in countries like India, Japan, and South Korea.
The rest of the world, like Africa, Latin America, and the Middle East, is experiencing an increase in the number of cardiovascular diseases and strokes, which can stimulate the demand for ischemic stroke surgeries. As health care initiatives grow and we see development in health care infrastructure, which is a trend in these regions, they are in fact becoming key players in the global ischemic stroke surgery market.
Major Competitors
Key players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., Stryker, Imperative Care, Johnson & Johnson Services Inc., Penumbra, Inc., and Phenox GmbH.
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY .................................. 14
1.1 OVERVIEW ............................................................................. 14
2 MARKET INTRODUCTION ............................... 15
2.1 DEFINITION ........................................................................... 15
2.2 SCOPE OF THE STUDY ........................................................... 15
2.3 RESEARCH OBJECTIVE .......................................................... 15
2.4 MARKET STRUCTURE ............................................................. 15
2.5 ASSUMPTIONS & LIMITATIONS .............................................. 16
3 RESEARCH METHODOLOGY ......................... 17
3.1 DATA MINING ........................................................................ 17
3.2 SECONDARY RESEARCH ........................................................ 18
3.3 PRIMARY RESEARCH ............................................................. 18
3.4 BREAKDOWN OF PRIMARY RESPONDENTS ............................. 19
3.5 FORECASTING TECHNIQUES .................................................. 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION ... 21
3.6.1 BOTTOM-UP APPROACH .................................................... 21
3.6.2 TOP-DOWN APPROACH ..................................................... 22
3.7 DATA TRIANGULATION .......................................................... 23
3.8 VALIDATION .......................................................................... 23
4 MARKET DYNAMICS ....................................... 24
4.1 OVERVIEW ............................................................................. 24
4.2 DRIVERS ................................................................................ 25
4.2.1 RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES .......................................................................... 25
4.2.2 ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS ........................................................ 25
4.2.3 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES .............................................................................. 26
4.3 RESTRAINTS ......................................................................... 27
4.3.1 LACK OF MEDICAL FACILITIES ........................................... 27
4.3.2 SHORTAGE OF SKILLED PROFESSIONALS ........................... 28
4.4 OPPORTUNITIES .................................................................... 29
4.4.1 R&D ACTIVITIES AND INVESTMENTS .................................. 29
5 MARKET FACTOR ANALYSIS ......................... 30
5.1 VALUE CHAIN ANALYSIS ....................................................... 30
5.1.1 R&D ..... 31
5.1.2 MANUFACTURING ............................................................. 31
5.1.3 DISTRIBUTION AND SALES ................................................. 31
5.1.4 POST-SALES MONITORING ................................................ 31
5.2 PORTER’S FIVE FORCES MODEL ............................................. 32
5.2.1 THREAT OF NEW ENTRANTS .............................................. 32
5.2.2 BARGAINING POWER OF SUPPLIERS .................................. 33
5.2.3 THREAT OF SUBSTITUTES ................................................. 33
5.2.4 BARGAINING POWER OF BUYERS ....................................... 33
5.2.5 INTENSITY OF RIVALRY ..................................................... 33
5.3 IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET ..................................................... 33
5.3.1 IMPACT ON SUPPLY CHAIN ............................................... 33
5.3.2 IMPACT ON PRODUCTION .................................................. 34
5.3.3 IMPACT ON DEMAND ........................................................ 34
5.4 EPIDEMIOLOGY ANALYSIS ..................................................... 34
5.4.1 INCIDENCE & PREVALENCE ................................................ 34
5.4.2 NUMBER OF PROCEDURES FOR THROMBECTOMY .............. 35
5.5 REGULATORY ANALYSIS/HEALTHCARE SYSTEM .................... 36
6 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY ........................... 37
6.1 OVERVIEW ............................................................................. 37
6.2 THROMBECTOMY .................................................................. 38
6.3 REVASCULARIZATION SURGERY............................................. 38
6.4 CAROTID ENDARTERECTOMY ................................................. 39
6.5 ANGIOPLASTY ....................................................................... 40
6.6 OTHERS ................................................................................ 41
7 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE ................................. 42
7.1 OVERVIEW ............................................................................. 42
7.2 CATHETER ............................................................................ 43
7.3 ASPIRATION SYSTEM ............................................................ 43
7.4 GUIDEWIRE ............................................................................ 44
7.5 MICROCATHETER .................................................................. 45
7.6 OTHERS ................................................................................ 45
8 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER ........................................... 46
8.1 OVERVIEW ............................................................................. 46
8.2 HOSPITALS AND CLINICS ...................................................... 47
8.3 AMBUATORY SURGICAL CENTRES .......................................... 47
8.4 OTHERS ................................................................................ 49
9 GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION ............................................... 50
9.1 OVERVIEW ............................................................................. 50
9.2 NORTH AMERICA ................................................................... 52
9.2.1 US........ 54
9.2.2 CANADA ........................................................................... 55
9.3 EUROPE ................................................................................ 57
9.3.1 GERMANY ......................................................................... 59
9.3.2 UK ....... 60
9.3.3 FRANCE ............................................................................ 61
9.3.4 ITALY ................................................................................ 62
9.3.5 SPAIN ............................................................................... 63
9.3.6 REST OF EUROPE ............................................................... 64
9.4 ASIA PACIFIC ........................................................................ 66
9.4.1 JAPAN .............................................................................. 68
9.4.2 CHINA ............................................................................... 69
9.4.3 INDIA ................................................................................ 70
9.4.4 AUSTRALIA ....................................................................... 71
9.4.5 SOUTH KOREA ................................................................... 72
9.4.6 REST OF ASIA PACIFIC....................................................... 73
9.5 REST OF THE WORLD ............................................................. 75
9.5.1 MIDDLE EAST .................................................................... 77
9.5.2 AFRICA ............................................................................. 78
9.5.3 LATIN AMERICA ................................................................ 79
10 COMPETITIVE LANDSCAPE ........................... 81
10.1 OVERVIEW ............................................................................. 81
10.2 MARKET SHARE ANAYISIS ..................................................... 82
10.3 COMPETITIVE BENCHMARKING ............................................. 83
10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET ............................................ 84
10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY
MARKET .............. 84
10.6 KEY DEVELOPMENT ANALYSIS .............................................. 85
10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES ....................... 85
10.7.1 MERGER & ACQUISITIONS .................................................. 86
10.7.2 AGREEMENT/MARKETING STRATEGIES.............................. 86
10.8 FINANCIAL MATRIX ............................................................... 87
10.8.1 SALES (USD MILLION), 2021 .............................................. 87
10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021 ................................................................... 87
11 COMPANY PROFILES ..................................... 88
11.1 MEDTRONIC PLC ................................................................... 88
11.1.1 COMPANY OVERVIEW ........................................................ 88
11.1.2 FINANCIAL OVERVIEW ....................................................... 89
11.1.3 PRODUCTS/SERVICES OFFERED ......................................... 89
11.1.4 KEY DEVELOPMENTS ......................................................... 90
11.1.5 SWOT ANALYSIS ............................................................... 90
11.1.6 KEY STRATEGIES ............................................................... 90
11.2 ABBOTT LABORATORIES ........................................................ 91
11.2.1 COMPANY OVERVIEW ........................................................ 91
11.2.2 FINANCIAL OVERVIEW ....................................................... 92
11.2.3 PRODUCTS/SERVICES OFFERED ......................................... 92
11.2.4 KEY DEVELOPMENTS ......................................................... 93
11.2.5 KEY STRATEGIES ............................................................... 93
11.3 BOSTON SCIENTIFIC CORPORATION ...................................... 94
11.3.1 COMPANY OVERVIEW ........................................................ 94
11.3.2 FINANCIAL OVERVIEW ....................................................... 94
11.3.3 PRODUCTS/SERVICES OFFERED ......................................... 95
11.3.4 KEY DEVELOPMENTS ......................................................... 95
11.3.5 KEY STRATEGIES ............................................................... 95
11.4 CORDIS CORPORATION .......................................................... 96
11.4.1 COMPANY OVERVIEW ........................................................ 96
11.4.2 FINANCIAL OVERVIEW ....................................................... 96
11.4.3 PRODUCTS/SERVICES OFFERED ......................................... 96
11.4.4 KEY DEVELOPMENTS ......................................................... 96
11.4.5 KEY STRATEGIES ............................................................... 96
11.5 KONINKLIJKE PHILIPS N.V ..................................................... 97
11.5.1 COMPANY OVERVIEW ........................................................ 97
11.5.2 FINANCIAL OVERVIEW ....................................................... 98
11.5.3 PRODUCTS/SERVICES OFFERED ......................................... 98
11.5.4 KEY DEVELOPMENTS ......................................................... 99
11.5.5 SWOT ANALYSIS ............................................................... 99
11.5.6 KEY STRATEGIES ............................................................... 99
11.6 STRYKER ............................................................................... 100
11.6.1 COMPANY OVERVIEW ........................................................ 100
11.6.2 FINANCIAL OVERVIEW ....................................................... 101
11.6.3 PRODUCTS OFFERED ......................................................... 102
11.6.4 KEY DEVELOPMENTS ......................................................... 102
11.6.5 SWOT ANALYSIS ............................................................... 103
1 1.6.6 KEY STRATEGIES ............................................................... 103
11.7 IMPERATIVE CARE ................................................................. 104
11.7.1 COMPANY OVERVIEW ........................................................ 104
11.7.2 FINANCIAL OVERVIEW ....................................................... 104
11.7.3 PRODUCTS OFFERED ......................................................... 104
11.7.4 KEY DEVELOPMENTS ......................................................... 104
11.7.5 KEY STRATEGIES ............................................................... 105
11.8 JOHNSON & JOHNSON SERVICES, INC. .................................. 106
11.8.1 COMPANY OVERVIEWS ...................................................... 106
11.8.2 FINANCIAL OVERVIEW ....................................................... 106
11.8.3 PRODUCTS OFFERED ......................................................... 107
11.8.4 KEY DEVELOPMENTS ......................................................... 107
11.8.5 SWOT ANALYSIS ............................................................... 108
11.8.6 KEY STRATEGIES ............................................................... 108
11.9 PENUMBRA, INC. ................................................................... 109
11.9.1 COMPANY OVERVIEW ........................................................ 109
11.9.2 FINANCIAL OVERVIEW ....................................................... 109
11.9.3 PRODUCTS OFFERED ......................................................... 110
11.9.4 KEY DEVELOPMENTS ......................................................... 110
11.9.5 SWOT ANALYSIS ............................................................... 111
11.9.6 KEY STRATEGIES ............................................................... 111
11.10 PHENOXYHENOX GMBH ........................................................ 112
11.10.1 COMPANY OVERVIEW ........................................................ 112
11.10.2 FINANCIAL OVERVIEW ....................................................... 112
11.10.3 PRODUCTS OFFERED ......................................................... 112
11.10.4 KEY DEVELOPMENTS ......................................................... 112
11.10.5 KEY STRATEGIES ............................................................... 112
12 APPENDIX........................................................ 113
12.1 REFERENCES ......................................................................... 113
12.2 RELATED REPORTS ................................................................ 114
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018–2035 (USD MILLION)
TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018–2035 (USD MILLION) 39
TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018-2035 (USD MILLION)
TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018-2035 (USD MILLION)
TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018-2035 (USD MILLION)
TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018-2035 (USD MILLION)
TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018-2035 (USD MILLION)
TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018-2035 (USD MILLION)
TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018-2035 (USD MILLION)
TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2035 (USD MILLION)
TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018-2035 (USD MILLION)
TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018-2035 (USD MILLION)
TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035 (USD MILLION)
TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018-2035 (USD MILLION)
TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018-2035 (USD MILLION)
TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018-2035 (USD MILLION)
TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 92 MERGER & ACQUISITIONS
TABLE 93 AGREEMENT/MARKETING STRATEGIES
TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 95 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 98 CORDIS CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 99 KONINKLIJKE PHILIPS N.V .: PRODUCTS/SERVICES OFFERED
TABLE 100 STRYKER: PRODUCTS OFFERED
TABLE 101 STRYKER: KEY DEVELOPMENTS
TABLE 102 IMPERATIVE CARE: PRODUCTS OFFERED
TABLE 103 IMPERATIVE CARE: KEY DEVELOPMENTS
TABLE 104 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
TABLE 105 JOHNSON & JOHNSON SERVICES, INC.: KEY DEVELOPMENTS
TABLE 106 PENUMBRA, INC.: PRODUCTS OFFERED
TABLE 107 PENUMBRA, INC.: KEY DEVELOPMENTS
TABLE 108 PHENOX GMBH: PRODUCTS OFFERED
TABLE 109 PHENOX GMBH: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL ISCHEMIC STROKE SURGERY MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINT: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ISCHEMIC STROKE SURGERY MARKET
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ISCHEMIC STROKE MARKET
FIGURE 1 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2021 & 2035 (USD MILLION)
FIGURE 2 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2021 & 2035 (USD MILLION)
FIGURE 3 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2021 & 2035 (USD MILLION)
FIGURE 4 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION 2021 & 2035 (USD MILLION)
FIGURE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION, 2021
FIGURE 6 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY 2021
FIGURE 7 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
FIGURE 8 EUROPE: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY 2021
FIGURE 9 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY 2021 & 2035 (USD MILLION)
FIGURE 10 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 11 ASIA PACIFIC ISCHEMIC STROKE SURGERY MARKET SHARE, BY COUNTRY 2021 & 2035 (USD MILLION)
FIGURE 12 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET SHARE (%), BY REGION, 2021
FIGURE 13 REST OF THE WORLD ISCHEMIC STROKE SURGERY MARKET SHARE, BY REGION 2021 & 2035 (USD MILLION)
FIGURE 14 MAJOR MANUFACTURERS MARKET SHARE (%) ANALYSIS, 2021
FIGURE 15 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 16 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
FIGURE 17 GLOBAL ISCHEMIC STROKE SURGERY MARKET: COMPETITIVE LANDSCAPE
FIGURE 18 SALES (USD MILLION), 2021
FIGURE 19 RESEARCH & DEVELOPMENT EXPENDITURE 2021
FIGURE 20 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 22 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
FIGURE 26 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 STRYKER: SWOT ANALYSIS
FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS
FIGURE 30 PENUMBRA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 PENUMBRA, INC.: SWOT ANALYSIS
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們